1Verstappen CCP,Postma TJ,Hoekman K,et al.Peripheral neuropathy due to therapy with paclitaxel,gemcitabine and cisplatin in patients with advanced ovarian cancer.J Neuro-Onocol,2003,63:201-205.
2Mangioni C,Bolis G,Pecorelli S,et al.Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.J Natl Cancer Inst,1989,81:1464-1471.
3Seidman AD,Berry DA,Woolf S,et al.CALGB9840:Phase Ⅲ study of weekly paclitaxel via 1 hour infusion versus standard 3 h infusion every third week in the treatment of metastatic breast cancer(MBC),with trastuzumab for HER2 positive MBC and randomized for Tin HER2 normal MBC.J Clin Oncol,2004,22(Suppl.14):s6.
4Dougherty PM,Cata JP,Cordella JV,et al.Taxolinduced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.Pain,2004,109:132-142.
5Gregg RW,Molepo JP,Monpetit VJ,et al.Cisplatin Neurotoxicity:The relationship between dosage,time and platinum concetration in neurologic tissues,and morphologic evidence.J Clin Oncol,1992,10:795-803.
6Kautio AL,Haanpa(a)M,Saarto T,et al.Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms.J Pain Symptom Manage,2008,35:31-39.
7Bosnjak S,Jelic S,Susnjar S,et al.Gabapentin for relief of neuropathic pain related to anticancer treatment:a preliminary study.J Chemother,2002,14:214-219.
8Nguyen VH,Lawrence HJ.Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias.J Clin Oncol,2004,22:1767-1769.
